Pos0254 a Novel Composite Endpoint Including Low Peripheral Joint Disease Activity State and Clear/almost Clear Skin in Patients With Active Psoriatic Arthritis: Post Hoc Analyses of 2 Phase 3, Randomized, Double-blind, Placebo-controlled Studies